Gossamer Bio
NEWS
A summary of IPOs from companies in the biotech and pharma world since January 1, 2019.
As 2018 comes to a close, analysts, journalists, investors and industry-watchers are studying their crystal balls to see what trends to watch in the upcoming year. Here are 7 trends most likely to be hitting the news cycle.
Gossamer Bio, headquartered in San Diego, announced plans for its initial public offering (IPO) just before Christmas.
A summary of IPOs from companies in the biotech and pharma world since December 1, 2018.
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
Let’s take a look at who made a splash in the pharma and biotech world the past week.
Since it first launched with $100 million in the bank earlier this year, Gossamer Bio has been on something of a roll.
This morning two companies announced deals that will yield potential benefits to multiple patient populations.
A look at the latest startups that have emerged in 2018 so far.
JOBS
IN THE PRESS